Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2023-11-02 00:00:00 ET · period of report 2023-11-01 · accession 0001062993-23-020015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-11-02 | 2023-11-01 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | F - Tax | $273.00 | -49.9K | 354.7K | -12% | -$13.63M |
| DM | 2023-11-02 | 2023-11-01 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $133.57 | +66.0K | 380.3K | +21% | +$8.82M |
| DM | 2023-11-02 | 2023-11-01 | BIO | SCHWARTZ NORMAN D | COB, Pres, CEO, Dir, 10% | M - OptEx | $0.00 | -66.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad B Common Stock | 2023-11-01 | F | D | 12,024 | $273.00 | 361,360 | D | — | — | |
| 2 | Common | Bio-Rad B Common Stock | 2023-11-01 | M | A | 15,000 | $159.32 | 373,384 | D | — | — | |
| 3 | Common | Bio-Rad B Common Stock | 2023-11-01 | F | D | 12,274 | $273.00 | 358,384 | D | — | — | |
| 4 | Common | Bio-Rad B Common Stock | 2023-11-01 | M | A | 16,000 | $139.56 | 370,658 | D | — | — | |
| 5 | Common | Bio-Rad B Common Stock | 2023-11-01 | F | D | 25,642 | $273.00 | 354,658 | D | — | — | |
| 6 | Common | Bio-Rad B Common Stock | 2023-11-01 | M | A | 35,000 | $119.80 | 380,300 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-11-01 | M | D | 35,000 | $0.00 | 0 | D | $119.80 · — to 2024-09-10 | 35,000 Bio-Rad B Common Stock | (F3) The option, representing a right to purchase a total of 35,000 shares, became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-11-01 | M | D | 16,000 | $0.00 | 0 | D | $139.56 · — to 2025-09-11 | 16,000 Bio-Rad B Common Stock | (F4) The option, representing a right to purchase a total of 16,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2023-11-01 | M | D | 15,000 | $0.00 | 0 | D | $159.32 · — to 2026-09-07 | 15,000 Bio-Rad B Common Stock | (F5) The option, representing a right to purchase a total of 15,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. |